This study presents a comprehensive evaluation of Copper Indium Gallium Selenide (CIGS) solar technology, benchmarked against crystalline silicon (c-Si) PERC PV technology. Utilizing a newly developed energy yield model, we analyzed the performance of CIGS in various environmental scenarios, emphasizing its behavior in low-light conditions and under different temperature regimes. The model demonstrated high accuracy with improved error metrics of normalized mean bias error (nMBE) ~ 1% and normalized root mean square error (nRMSE) of ~ 8%-20% in simulating rack mounted setup and integrated PV systems.
View Article and Find Full Text PDFBackground: Type 2 diabetes mellitus (T2DM) intensifies the clinical symptoms of heart diseases and leads to a worse prognosis in heart failure patients. Although hypertrophic cardiomyopathy (HCM) and DM rarely co-occur, particularly in older individuals, the impact of DM on cardiac function and outcomes in individuals with HCM remains insufficiently understood.
Methods: A total of 421 HCM patients were included and followed up in a prospective cohort study (mean 68.
For the purpose of determining the characteristics of the Cyanidin-3-O-glucoside chloride (COGC) dye, both an FT-IR spectrometer and a UV-Visible spect rometer were employed through the process. At a wavelength of 473 nm, a diode-pumped solid-state (DPSS) laser with an adjustable wavelength was used to quantify the thermally induced optical nonlinearity of the dye in a solvent composed of dimethylformamide. For the purpose of measuring the optical response, the Z-scan technique was utilised.
View Article and Find Full Text PDFIntroduction: The renin-angiotensin-aldosterone system (RAAS) plays a pivotal role in regulating blood pressure (BP), with dysregulation of RAAS resulting in hypertension and potentially heart failure (HF), myocardial infarction (MI), cardio-renal syndrome, and stroke. RAAS inhibitors, such as angiotensin-converting enzyme inhibitors (ACEis) and angiotensin receptor blockers (ARBs), have advantages beyond BP control. However, differences between these two drug classes need to be considered when choosing a therapy for preventing cardiovascular events.
View Article and Find Full Text PDFAsian Pac J Cancer Prev
September 2024
Background: Enhancing prognostication in Hepatocellular Carcinoma (HCC) remains an unmet need, especially in patients with preserved liver function. This study aimed to integrate the Platelet-to-White Blood Cell Ratio (PWR) with albumin-bilirubin (ALBI) and platelets-albumin-bilirubin (PALBI) scores for improved assessment of mortality and treatment responses in hepatocellular carcinoma (HCC) patients.
Methods: In this prospective study, 262 patients with hepatocellular carcinoma (HCC) were included, with basic data collected and followed up for one year or until death.